Published in J Med Chem on December 22, 2014
Improving the clinical impact of biomaterials in cancer immunotherapy. Oncotarget (2016) 0.83
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res (2009) 3.30
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet (2002) 3.21
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
Malaria vaccine developments. Lancet (2004) 1.77
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol (2007) 1.67
Immunoediting of cancers may lead to epithelial to mesenchymal transition. J Immunol (2006) 1.65
Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol (2010) 1.65
Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol (2005) 1.56
Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol (2002) 1.51
The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med (2002) 1.48
Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity. Leuk Lymphoma (2012) 1.43
Lipidic systems for in vivo siRNA delivery. AAPS J (2009) 1.33
Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis (2003) 1.26
Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect Immun (2005) 1.25
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem (2006) 1.23
Modern subunit vaccines: development, components, and research opportunities. ChemMedChem (2013) 1.22
MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res (2012) 1.21
Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria. J Immunol (2002) 1.19
Ultrafast synthesis of ultrahigh molar mass polymers by metal-catalyzed living radical polymerization of acrylates, methacrylates, and vinyl chloride mediated by SET at 25 degrees C. J Am Chem Soc (2006) 1.18
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis (2007) 1.16
What really happens to dendritic cells during malaria? Nat Rev Microbiol (2008) 1.14
Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog (2007) 1.12
M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysis. BMC Microbiol (2005) 1.10
Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology (2006) 1.10
Self-adjuvanting lipopeptide vaccines. Curr Med Chem (2008) 1.10
Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother (2013) 1.10
Whole parasite blood stage malaria vaccines: a convergence of evidence. Hum Vaccin (2010) 1.09
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leuk Lymphoma (2012) 1.09
High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis (2004) 1.08
Contact lens sensors in ocular diagnostics. Adv Healthc Mater (2014) 1.08
Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol (2009) 1.07
emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development. J Clin Microbiol (2009) 1.06
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol (2003) 1.06
High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol (2011) 1.06
Prospective surveillance of streptococcal sore throat in a tropical country. Pediatr Infect Dis J (2009) 1.06
Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. J Clin Invest (2010) 1.05
RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol (2005) 1.03
Rational design of immunostimulatory siRNAs. Mol Ther (2010) 1.02
The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria. Proc Natl Acad Sci U S A (2003) 1.01
Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv (2006) 1.01
Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis (2009) 1.01
Loss of PKR activity in chronic lymphocytic leukemia. Int J Cancer (2004) 0.99
A case for whole-parasite malaria vaccines. Int J Parasitol (2007) 0.99
Rodent blood-stage Plasmodium survive in dendritic cells that infect naive mice. Proc Natl Acad Sci U S A (2011) 0.98
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help. J Immunol (2013) 0.98
Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection. PLoS One (2009) 0.97
Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano (2012) 0.97
Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function. J Immunol (2007) 0.95
Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proc Natl Acad Sci U S A (2009) 0.95
Interactions between malaria parasites and the host immune system. Curr Opin Immunol (2005) 0.95
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology (2012) 0.94
Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun (2003) 0.94
Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J Exp Med (2013) 0.94
M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats. Res Microbiol (2005) 0.94
Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew Chem Int Ed Engl (2010) 0.94
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. J Med Chem (2007) 0.94
Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use. Pharm Res (2008) 0.94
Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus. J Infect Dis (2005) 0.93
What have we learnt from mouse models for the study of malaria? Eur J Immunol (2009) 0.92
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. Bioorg Med Chem (2008) 0.92
CD8+ T lymphocyte-mediated loss of marginal metallophilic macrophages following infection with Plasmodium chabaudi chabaudi AS. J Immunol (2006) 0.92
RNA interference for the treatment of cancer. Drug News Perspect (2006) 0.92
Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol J (2005) 0.92
Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res (2012) 0.92
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr Drug Deliv (2005) 0.91
The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation. J Interferon Cytokine Res (2006) 0.91
Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1. Infect Immun (2002) 0.91
Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. J Gen Virol (2008) 0.91
Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res (2011) 0.91
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo. Immunol Cell Biol (2011) 0.90
Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine. J Control Release (2009) 0.90
Escaping the immune system: How the malaria parasite makes vaccine development a challenge. Trends Parasitol (2013) 0.89
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89
Retracted Dendrimer nanocarriers as versatile vectors in gene delivery. Nanomedicine (2009) 0.89
Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol (2005) 0.89
Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis (2012) 0.89
An influenza virus-inspired polymer system for the timed release of siRNA. Nat Commun (2013) 0.88
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197. Hum Vaccin Immunother (2012) 0.88
Cross-species malaria immunity induced by chemically attenuated parasites. J Clin Invest (2013) 0.88
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. J Control Release (2011) 0.88
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun (2002) 0.87
Reusable, robust, and accurate laser-generated photonic nanosensor. Nano Lett (2014) 0.87
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One (2012) 0.87